Indlela Yokufuduka Kuvela Guillain-Barré
Ubunzima bukaGuillain-Barré Syndrome buhluka kakhulu kwimeko ukuya kwimeko. Ngamanye amaxesha inokuba yinto ecasulayo, inobunzima obuthathaka kunye nobuthathaka obungasetyenziswanga ngaphezu kwezandla. Ngamanye amaxesha, uGuilin-Barré unokuba ngumonakalo okanye ubulawe.
Ngenxa yokungaqiniseki, oogqirha bavame ukubuza umntu osola ukuba uGilin-Barré syndrome ukuba ahlale esibhedlele ukuze bakwazi ukujongwa ngokugqithiseleyo kude kube ngcono iimpawu.
Kunokuba nzima ukuqikelela ukuba kuya kuthatha ixesha elingakanani. Uninzi lwabantu abane-Guillain-Barré syndrome lufikelela kwindawo yabo ebuthathaka phakathi ezimbini okanye ezintathu kwiiveki emva kokuqala ukuphawula iimpawu zabo.
Uhlolo loBhedlele
Ukuze uqaphele ukuba lesi sifo sitshintsha njani amandla omntu wokuphefumula, imilinganiselo yokuphefumla ithathwa rhoqo. Lezo nyathelo zivame ukuquka amandla anyanzelekileyo okanye amandla aphefumlelweyo, okulinganisa indlela umntu angaphefumula ngayo okanye ngokulandelanayo. Iimviwo eziqhelekileyo zingenziwa kwakhona ukuqinisekisa ukuba isiguli asifumani lukhuni kakhulu.
Ukuba ubuthathaka buqhubela phambili kwinqanaba elithile, iliso lingafuneka ukuba lwenzeke kwiyunithi yonyango olukhuselekileyo, apho kungena iqela lokungenisa umoya ngokukhawuleza ukuba kuyimfuneko. Amanyathelo angaphezulu angathathwa ukuze agcine iso kwiimpawu ezizimeleyo , njengezinga lentliziyo kunye neshyhym.
Emva kokuba ubuthathaka buqalise ukuphucula, inxalenye ethile yokuvuselelwa iyakwenzeka ngelixa esesibhedlele njengoko kwenziwe amalungiselelo enoba yintoni inkxaso eyongezelelweyo efunekayo.
Unyango
Akukho naluphi unyango lwe-Guillain-Barré syndrome, kodwa ukuhlaselwa kungacetyiswa ngokucoca ama-antibodies engxaki kwigazi kunye ne-plasmapheresis okanye ngokunika i- immunoglobulins (IVIg) engenayo i- intravenous (i-IVIg) ukuze kulungelelaniswe i-antibodies.
I-Plasmapheresis , eyaziwa nangokuthi utshintsho lwe-plasma, ibandakanya inxalenye yamanzi yegazi (kunokuba iiseli zegazi) isuswe ize ithathelwe endaweni ye-plasma engenazo i-antibody-free.
Le nkqubo ivame ukuqhutyelwa phakathi kwamaxesha amathathu ukuya kwezihlanu, ngokuqhelekileyo kunye nosuku phakathi kweeseshoni ukuze umzimba uphendule kwi-plasma entsha. Izingozi zimbalwa kodwa ziquka iingxaki zegazi.
I-IVIg i-immunoglobulin ejoyiweyo eboniswe ukunciphisa ixesha elifunekayo lokuba umntu abuyele eGuillain-Barré, nangona kungekho mntu uyazi kakuhle ukuba kutheni kusebenza. Inani lemngcipheko lifana ne-plasmapheresis, kodwa kunengxaki yegazi, i-IVIg inokukhokelela ekusebenziseni ukuphazamiseka, i- hepatitis , okanye iingxaki zeengtso.
Uphando lubonisa ukuba ii-IVIg kunye ne-plasmapheresis zinokulingana kakuhle ekuphatheni i-Guillain-Barré syndrome, kwaye akukho nzuzo ecacileyo yokwenza kokubili kunye. Kwiimeko ezinzima, abanye oogqirha baya kusenza ngamanye amaxesha ukutshintshwa kwe-plasma elandelwa yi-IVIg.
Ngethuba besesibhedlele, abasebenzi bezonyango baya kugcina isohlo elisezantsi kubantu abane-Guillain-Barré syndrome ukuqinisekisa ukuba ubuthathaka abuphazamisi nemisebenzi ebalulekileyo njengokugwinya ngokuphepha nangokuphefumula. Ukuba i-Guillain-Barré iqhubela phambili kweli nqanaba, kungenokuba kuyimfuneko ukuba intubate isigulane kwaye uyibeke kwi-air ventical.
Ukubuyisela kunye nokuhlaziya
Uninzi lwabantu luphuma kakuhle ukusuka kwi-Guillain-Barré syndrome, kodwa oku kuyahluka phakathi kwamatyala.
Ezinye iifom, ezinjenge-AMSAN, zifuna ixesha elide lokubuyela. Xa kunzima kakhulu kwimeko, ixesha elide lokuphucula. Amathambo athatha ixesha elide ukukhula emva - imitha eyi-millimitha ngosuku - kwaye ukuba umonakalo uphezulu, ungathatha unyaka okanye ngaphezulu ukuze uphinde uphinde usebenze. Kwezinye iimeko, ezinye iingxaki, ezifana nobunzima kunye nokunyuka kwamanwe amancinci okanye ukutshintshwa kwezinto ezincinci, kuya kuhlala.
Kufuneka rhoqo unyango lwezinto eziphathekayo kunye nokusebenza ukuze izigulane zifumane ngokupheleleyo. Abasebenzi beengcali baye bancedise ukufumana izixhobo kunye nezinye iindlela zokugcina abantu bazimeleyo njengokuba kunokwenzeka, ngoxa iingcali zempilo zinceda ngokuhamba nokuhamba.
Ingxoxo kunye nolululwazi lweelwimi lunokufuneka ukuba iimfucuza zomlomo kunye nomqala zibandakanyeke.
UGuilin-Barré unokuba ngumngcipheko omkhulu, kodwa ngaphezu kwe-95% yexeshana, abantu baphila ngokukhawuleza. Ukuphindaphinda akuqhelekanga, kunye neepesenti ezicatshulweyo zibe phakathi kwe-2-6%. Umendo unokuba ngumde kwaye ucelomngeni, kodwa ekugqibeleni, abaninzi abantu banako ukuhamba eGuillain-Barré emva kwabo.
Imithombo:
I-Ropper AH, i-Samuels MA. I-Adams kunye neMigaqo yeVictor ye-Neurology, 9-ed: I-McGraw-Hill Companies, Inc., 2009. Ilungu leMcCabe, u-O'Connor EJ.
I-Yuen T. Ngoko, i-Continuum: I-Peripheral Neuropathies, i-Immune-Mediated Neuropathies, uMqulu 18, iNombolo 1, ngoFebruwari 2012.